ETFMG Alternative Harvest ETF
Gauging the Bullish-Bearish Sentiment on Aphria
The short interest position on a stock is one quick way to gauge the bullish and bearish sentiment on a stock.
Why Product Landscape Design Matters for Cannabis Stocks
The popularity of various cannabis consumption methods could guide the product landscape design for cannabis companies.
SMG’s Margin Expectations Could Be Concerning
The Scotts Miracle-Gro Company (SMG) continues to face margin headwinds in the lawn and garden segment.
Analysts’ Estimates for Canopy Growth’s Earnings
Canopy Growth (WEED) (CGC) is expected to report a loss per share of ~0.15 Canadian dollars.
MedMen’s Territory Expansion: The Recent Agreements
MedMen (MMNFF) has entered into agreements with different companies to expand its footprint. We outline a few of the recent agreements below.
Tilray’s Q2 2018 Results and Its Strategic Focus
Tilray’s (TLRY) average selling prices and sales volume improved YoY in the second quarter. The company sold 1,514 kilograms during the quarter.
Here’s What Jim Cramer Had to Say about the Cronos-Altria Deal
Jim Cramer said Altria’s acquisition of a 45% stake in Cronos Group last week was a “smart move” for Altria.
Law Firms Investigate Aphria for Potential Violations
Due to Aphria’s (APHA) (APHQF) broad sell-off, several investors lost their investments. The investments might not be recovered.
Will Canopy Growth Add Value to Constellation Brands?
Constellation Brands said that Canopy Growth is a platform that can cater to medical and recreational customers.
Cronos Group Invests in the Future
Through Cronos Group’s partnership with Ginko Bioworks, the company aims to produce cannabis through fermentation.
Innovative Industrial Properties Declared Q1 Dividend
On March 12, Innovative Industrial Properties’ board declared its first-quarter dividend. The company declared a dividend of $0.45 per share.
Aurora Cannabis: Analysts’ Projections
Analysts expect Aurora Cannabis to report a gross income of 177 million Canadian dollars in 2019 and 508 million Canadian dollars in 2020.
Does Cronos Group Look Expensive Compared to Its Peers?
Cronos Group (CRON) has been on a declining trend for a while. The stock rose to a peak of ~30 Canadian dollars in February.
Why Aurora Cannabis Calls Itself a ‘Medical Company at Heart’
Aurora Cannabis (ACB) reported its Q2 earnings yesterday, which gave us a glimpse of recreational cannabis sales activity and what to expect from peers’ (MJ) upcoming earnings.
Top Developments in the Cannabis Industry’s Early Years
In the second half of 2018, the cannabis industry remained busy. As the cannabis sector experienced a boom, there was a lot of excitement among investors.
APHA, CTST, KSHB, and HEXO Gain to Break Their Losing Streaks
Cannabis stocks have recently experienced weakness amid concerns surrounding a global slowdown and companies missing their earnings expectations.
Cannabis Legalization: Four Governors Met in New York
The Day reported that New York, New Jersey, Connecticut, and Pennsylvania’s governors met and agreed on basic guidelines for legalizing marijuana.
TLRY, CGC, CRON, and CTST Continue to Slide on April 11
The first half of April 11 proved to be yet another dampener for cannabis investors’ expectations.
Tilray’s November Price Target and Recommendation Update
Tilray (TLRY), which reported its earnings on November 13, missed both top-line and bottom-line consensus estimates.
SLNG, IIPR, and CTST Gain amid Sector Weakness
The broader cannabis sector has traded largely in the negative so far on April 8 as investors have continued to be bearish.
Comparing the Valuation Multiples of Cannabis Stocks
In this part of our cannabis valuation series, we’ll discuss the multiples of the remaining cannabis stocks and compare them to the peer (MJ) median of 24x.
iAnthus to Open Three Dispensaries in Florida by End of 2018
Today, iAnthus Capital Holdings (ITHUF) announced it will open its first dispensary in Florida on December 19.
Gundlach Compares Cannabis to Bitcoin
Jeffrey Gundlach predicted bitcoin’s (BTC) crash after the cryptocurrency’s peak in December 2017.
Big News: Cannabis Edibles in Alberta Stores
Many people expected the Cannabis 2.0 products, including cannabis edibles, to hit the markets by mid-December 2019. However, the products got delayed.
APHA, CTST, and CRON Continue to Weaken on May 1
The cannabis sector has been trading broadly flat ahead of the first-quarter earnings season.
Kamala Harris: Presidential Candidate for Legalizing Marijuana
Senator Kamala Harris, who also announced her 2020 presidential bid, supports legalizing marijuana at a federal level.
Cannabis Roundup: ACB, HEXO, and CTST Lead the Pack
On March 13, during the first half of the day, the overall cannabis sector traded higher.
Cannabis Stocks Continue to Struggle on the Last Day of April
The cannabis sector has continued to struggle on the last day of April, and it may very well end up in negative territory.
Cannabis Roundup: HEXO, WEED, ACB, and CTST
The broader US markets were relatively flat today. Weakness in the cannabis sector continued, with the ETFMG Alternative Harvest ETF down 0.4%.
Will Santa Claus Rally Boost Cannabis Stocks?
On December 26, a Santa Claus rally seems to be in full swing. This effect pushed the S&P 500 (SPX) and Nasdaq Composite Index (COMP) to record highs.
Planet 13 and Wayland Group Posted Strong Performance Last Week
Between March 29 and April 5, HMMJ and MJ rose 0.9% and 0.4%, respectively.
Cannabis Sector: A Week in Review for Sept 20
Last week, the overall cannabis sector remained subdued. Sector ETFs, such as the Horizons Marijuana Life Sciences ETF (HMMJ), closed about 8.15% lower.
Aphria: Last Week Was Eventful
On December 27, Aphria came in play after Green Growth Brands announced its bid to take over the company for 11 Canadian dollars per share.
Why Canopy Growth Is a ‘Buy’ before Its Earnings
Despite the surge in May, Canopy Growth is still trading at a 54.3% discount from its 52-week high of $59.74. So, should you buy the stock?
Bruce Linton Joins Vireo Health as Executive Chairman
Medical cannabis company Vireo Health International announced that it appointed Bruce Linton as its Executive Chairman. Linton co-founded Canopy Growth.
What Analysts Recommend for Cannabis Stocks in March
Most of the major cannabis stocks are in the red on a year-to-date basis.
Curaleaf Opens Medical Marijuana Dispensary in Tallahassee
On November 16, Curaleaf Holdings announced that the company opened Tallahassee’s largest medical marijuana dispensary.
Cannabis Stocks Up, Broader Equity Market Falls
Today, cannabis stocks are trading in the green despite the weakness in the broader market. The ETFMG Alternative Harvest ETF was up 2.5% as of 2:00 PM ET.
How Analysts View Cresco Labs before Its Q1 Release
Cresco Labs (CRLBF) is slated to release its first-quarter earnings on May 29.
CGC: How the Future Looks Under Its New CEO
On December 9, Canopy Growth (CGC) appointed David Klein as its new CEO effective January 14. He’s the current CFO of Constellation Brands.
TGOD: New IPO in the Cannabis Space Last Week
The cannabis industry has seen a surge in producers seeking to gain a piece of the Canadian recreational cannabis market (MJ).
Aurora Cannabis Comments on Coca-Cola Development
Today, Aurora Cannabis (ACB) noted that while it doesn’t have a confirmed deal with Coca-Cola, it doesn’t reject the Coca-Cola development.
Tilray and Green Thumb Gain amid Broader Market Weakness
Not all of the cannabis companies experienced a loss on April 2. Tilray (TLRY) rose ~1.6% around the middle of the day.
Cannabis Stocks Had a Mixed Performance Last Week
Cannabis ETFs traded on a largely negative note last week.
What to Expect from Cannabis Player Curaleaf’s Q3 Earnings
A look at Curaleaf Curaleaf Holdings (LDVTF) is one of the leading cannabis operators in the United States. Curaleaf Holdings has announced that it will release its third-quarter earnings results on November 26. We’ll discuss analysts’ estimates for its EPS and revenue in this article. The chart above compares Curaleaf Holdings’ revenues since the third […]
Ups and Downs in the Cannabis Space Last Week
The cannabis space was mostly positive last week. The Horizons Marijuana Life Sciences ETF (HMMJ) and the ETFMG Alternate Harvest ETF (MJ) gained 5.2% and 4.2%, respectively.
IIPR Stock Moves Higher after New Debt Is Raised
Last week, Innovative Industrial Properties (IIPR) offered $125 million in senior notes, giving initial investors the option to exercise $18.75 million in additional principal amount notes.
Aurora Cannabis Releases Update on Cannabis 2.0
Aurora Cannabis (ACB) is going through a rough patch. This year, the company’s stock has lost 60.9% of its value as of December 23.
Cannabis Stocks: What Happens in a Recession?
As market analysts increasingly predict an upcoming global recession, we take a look at the impact of a recession on cannabis stocks.
What’s the Market Potential for CBD?
The FDA has issued warning letters to 15 companies involved in illegal sales of non-psychoactive CBD products. What’s the legal market’s potential?
Cannabis Updates: New Listings, Price Action, and Ratings
The cannabis sector showed some weakness last week, and the Horizons Marijuana Life Sciences ETF (HMMJ) lost 3.0% while the ETFMG Alternate Harvest ETF (MJ) lost 3.4%.
Will Mexico Legalize Cannabis by the End of the Month?
With more countries now warming up to cannabis, let’s look at how Mexico is shaping up in terms of cannabis legalization.
One Chart That Shows What Makes Cannabis Attractive to Altria
As the cannabis space has increasingly become crowded, companies such as Cronos Group would greatly benefit from a company such as Altria.
Supreme Cannabis’ Target Price Changed in December
Supreme Cannabis has been one of the worst performers in the cannabis sector year-to-date with a return of -49% as of December 19.
Cannabis Stocks Roundup: Today’s Gains and Losses
In the previous part of this series, we saw that most cannabis stocks (MJ) were trending lower today, but there were some gains as well.
Cannabis Investing in 2019: A Year of Big Reversals
The cannabis sector has seen a bit of a Jekyll and Hyde situation in 2019. In the first half, cannabis ETFs rose, but in the second half, they plummeted.
Vaping and Cannabis Stocks: Piper Jaffray Weighs In
On October 8, Piper Jaffray senior analyst Michael Lavery voiced his opinions about the impact of vaping on cannabis stocks in an interview.
Why Origin House’s Acquisition Is Vital for Cresco Labs
On December 31, 2019, Origin House (OH) announced that its shareholders had approved Cresco Labs’ (CRLBF) acquisition plan.
OrganiGram Was the Biggest Cannabis Gainer Last Week
Cannabis sector Overall, the cannabis sector broadly ended in the positive territory for the week ending March 1—compared to the closing on February 22. The Horizons Marijuana Life Sciences ETF (HMMJ) rose nearly 4.6%, while the ETFMG Alternative Harvest ETF (MJ) rose ~1.6%. Let’s look at how some of the major cannabis stocks performed last week. […]
APHA, CRON, and Other Cannabis Stocks Resume Their Falls
On May 2, the overall sentiment surrounding the cannabis sector appeared to be negative.
Comparing GW Pharmaceuticals’ Returns to Peers
GW Pharmaceuticals has received a “strong buy” rating from four analysts, while eight have rated it as a “buy” or some equivalent.
OrganiGram Receives Expansion License from Health Canada
On Monday, OrganiGram Holdings (NASDAQ:OGI) announced that it received a license from Health Canada to expand its Phase 5.
Comparing Cannabis Stocks’ Valuation Multiples in November
Aurora Cannabis (ACB) was trading at a multiple of 26.4x, which declined from 34x in October.
Can Canopy Growth’s Q3 Earnings Lift the Cannabis Sector?
On Friday, Canopy Growth will report its third-quarter earnings before the market opens. Investors will be watching the results closely.
Jeff Sessions’ Resignation Could Be Good News for Cannabis Stocks
On November 7, US Attorney General Jeff Sessions resigned from his position.
OrganiGram Stock Falls after Disappointing Q3 Earnings
Today, OrganiGram Holdings (NASDAQ:OGI) reported its third-quarter earnings. As expected, the results were disappointing.
Aurora Cannabis Appoints New Chief Commercial Officer
As the demand for Cannabis 2.0 products continues to rise, Aurora Cannabis announced the appointment of Miguel Martin as its new chief commercial officer.
Curaleaf Holdings Completes Curaleaf NJ’s Acquisition
Curaleaf Holdings (OTCMKTS:CURLF) continued its expansion by completing the acquisition of Curaleaf NJ, which owns a medical license in New Jersey.
HEXO Enters Israel’s Medical Marijuana Market, Stock Surges over 18%
Today, HEXO announced that it launched its medical marijuana products in Israel. The company signed a two-year agreement with an Israeli cannabis company.
Is Aphria or OrganiGram a Better Buy for Investors?
Analysts expect Aphria to report revenues of $631.8 million in the next four quarters. Management will focus on the medical and recreational sectors.
What to Expect from OrganiGram’s Q3 Earnings
OrganiGram will likely report its third-quarter earnings before the market opens on July 21. Overall, there isn’t much hope.
Aphria Stock Rose More than 8% after Stifel’s Upgrade
Aphria (NYSE:APHA) received a bullish call from Stifel. On Monday, Stifel upgraded the stock from a “hold” to a “buy” rating.
Curaleaf Plans a Nationwide Expansion of ‘Select’ Brand
Curaleaf (OTCMKTS:CURLF) acquired a “Select” brand in February 2020. The company received positive feedback in medical and adult-use markets.
Why Did Raymond James Downgrade OrganiGram?
On Monday, Cantech Letter reported that Raymond James downgraded OrganiGram from an “outperform” rating to a “market perform” rating.
Green Thumb Keeps Expanding Its Operations in Las Vegas
On June 27, Green Thumb Industries (OTCMKTS:GTBIF) opened its fifth Essence brand store in Las Vegas and its 48th retail store in the US.
Canopy Growth Announces Initiatives to Regain Market Share
In the fourth quarter, Canopy Growth (NYSE:CGC)(TSE:WEED) lost market share due to increased competition in value products.
Why Canadian Cannabis Sales Dipped Slightly in April
In April, cannabis sales came in at $180.1 million—0.6% down from the March sales. So, considering the spike in March, the sales weren’t disappointing.
MedMen’s Medical Marijuana Dispensary License Revoked in Virginia
The Virginia Board of Pharmacy voted not to extend MedMen’s conditional license to operate a medical marijuana dispensary in Staunton, Virginia.
Tilray Rebounded in Q1, Most Analysts Recommend a ‘Hold’
Tilray hasn’t reported a positive EBITDA yet. Analysts expect the company to become profitable in the first quarter of 2021.
Canopy Growth CEO Expects US to Legalize Cannabis by 2022
Amid the growing support for cannabis legalization, Canopy Growth (NYSE:CGC) CEO David Klein expects the federal government to legalize marijuana by 2022.
Top 2 Cannabis Stocks to Buy, Interest in the Sector Reignites
After underperforming the broader equity markets in the first quarter, the cannabis sector has been showing a strong recovery in the second quarter.
Curaleaf Expands Select Brand Medical Products in Connecticut
On Monday, Curaleaf Holdings announced that it will expand its Select brand products in Connecticut. The products will be available at medical dispensaries.
Canada’s Cannabis Oil Exports Rose More than 450% in 2019
Canada, with first-mover advantage, has been exploring new territories to export its cannabis oil. Last year, the company reported to 17 counties.
IIPR Acquires Another Property in Pennsylvania
Innovative Industrial Properties has continued its aggressive expansion. IIPR acquired a new property in Pennsylvania from Holistic Industries.
Illinois Reports Record Recreational Cannabis Sales in May
Illinois sold recreational cannabis worth $44.3 million in May—the highest amount since it legalized recreational sales in January this year.
Vireo Health Terminates Bruce Linton as Its Executive Chairman
On Monday, Vireo Health announced that it terminated Bruce Linton as its executive chairman immediately. He joined the company in November 2019.
Why California’s Legal Cannabis Sales Could Fall This Year
The budget proposed by Governor Gavin Newsom projected a decline in California’s cannabis sales. COVID-19 induced a recession in the US economy.
Closing Facility Could Cost Tilray $28 Million in Non-Cash Charges
On May 26, Tilray (NASDAQ:TLRY) announced that it will permanently shut down its High Park Gardens facility located in Leamington, Ontario.
Why Are Canadian Cannabis Companies Leaving Jamaica?
Canadian cannabis companies are frustrated by the Jamaican government’s inaction. They have decided to cut their losses and exit the Jamaican market.
Why OrganiGram Stock Rose More than 11% Yesterday
OrganiGram (NASDAQ:OGI) had good news for patients who use cannabis for medical purposes. The company expanded its medical cannabis offerings.
Curaleaf: Analysts’ Recommendations after Its Q1 Earnings
Earlier this week, Curaleaf (OTCMKTS:CURLF) reported its first-quarter earnings. The company missed analysts’ revenue expectations.
Aurora Cannabis to Enter US CBD Market, Stock Rises over 30%
On Wednesday, Aurora Cannabis (NYSE:ACB) announced that it has signed an agreement to acquire Reliva—a US-based CBD company.
Why Did Curaleaf Report a Mixed Q1 Performance?
On Monday, Curaleaf (OTCMKTS:CURLF) reported its first-quarter earnings after the market closed. The company reported revenue of $96.5 million.
Why Curaleaf Is a ‘Buy’ before Its Q1 Earnings
Analysts expect Curaleaf’s EBITDA to rise during the quarter. They expect the company to report an EBITDA of $15.7 million.
Charlotte’s Web Reports Mixed Q1 Performance
Today, Charlotte’s Web reported a mixed first-quarter performance. For the quarter ended on March 31, the company reported revenues of $21.7 million.
GW Pharmaceuticals Stock Rises on Higher Epidiolex Sales
On Monday, GW Pharmaceuticals reported its first-quarter earnings. The company beat analysts’ revenue, EBITDA, and EPS expectations.
Tilray Posts Q1 Results, Stock Falls, and Net Losses Widen
On Monday, Tilray (NASDAQ:TLRY) reported its first-quarter earnings after the market closed. For the quarter, the company posted revenues of $52.1 million.
Why Did Aphria Stock Fall 7% on May 8?
On May 8, Aphria’s (NYSE:APHA) management announced that it agreed to repurchase its convertible senior notes from some holders outside of Canada.
Why Analysts Are Bullish before Charlotte’s Web’s Q1 Earnings
Charlotte’s Web Holdings (OTCMKTS:CWBHF)(NYSEARCA:CWEB) will likely report its first-quarter earnings before the market opens on May 14.
Tilray’s Q1 Earnings Could Boost Its Stock Price
The meltdown in global financial markets amid COVID-19 dragged Tilray stock down to $2.43 on March 18. Since then, the stock has recovered.